Company Becton, Dickinson and Company Wiener Boerse

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

End-of-day quote Wiener Boerse 03:30:00 24/04/2024 am IST 5-day change 1st Jan Change
218.5 EUR -0.36% Intraday chart for Becton, Dickinson and Company +0.60% -0.68%

Business Summary

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:

- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;

- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;

- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.

Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).

Number of employees: 73,000

Sales per Business

USD in Million2022Weight2023Weight Delta
Medical
49.1 %
8,841 46.9 % 9,502 49.1 % +7.48%
Life Sciences
26.5 %
5,564 29.5 % 5,133 26.5 % -7.75%
Interventional
24.4 %
4,464 23.7 % 4,736 24.4 % +6.09%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
57.4 %
10,722 56.8 % 11,113 57.4 % +3.65%
EMEA
21.9 %
4,043 21.4 % 4,244 21.9 % +4.97%
Greater Asia
15.0 %
3,047 16.1 % 2,913 15.0 % -4.40%
Other
5.7 %
1,058 5.6 % 1,102 5.7 % +4.16%

Managers

Managers TitleAgeSince
Chief Executive Officer 50 01/09/01
Director of Finance/CFO 52 06/21/06
Chief Tech/Sci/R&D Officer 48 01/19/01
Chief Tech/Sci/R&D Officer - 29/21/29
Chief Tech/Sci/R&D Officer 54 01/22/01
Chief Tech/Sci/R&D Officer 54 04/12
Compliance Officer - 01/04/01
Public Communications Contact - 01/18/01
Investor Relations Contact - 01/16/01
General Counsel 56 01/19/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 73 24/02/24
Director/Board Member 73 29/13/29
Director/Board Member 69 26/10/26
Director/Board Member 59 10/18/10
Director/Board Member 66 29/17/29
Director/Board Member 62 23/16/23
Director/Board Member 68 20/06/20
Director/Board Member 61 28/22/28
Chief Executive Officer 50 01/09/01
Director/Board Member 61 21/21/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 370,594,232 287,994,622 ( 77.71 %) 81,692,000 ( 22.04 %) 77.71 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.042 %
26,123,450 9.042 % 6 464 M €
BlackRock Advisors LLC
5.964 %
17,228,858 5.964 % 4 263 M €
12,915,202 4.470 % 3 196 M €
Eaton Vance Management
3.708 %
10,711,553 3.708 % 2 651 M €
T. Rowe Price International Ltd.
3.595 %
10,385,888 3.595 % 2 570 M €
T. Rowe Price Investment Management, Inc.
2.543 %
7,345,799 2.543 % 1 818 M €
Wellington Management Co. LLP
2.310 %
6,672,346 2.310 % 1 651 M €
Merrill Lynch International
1.930 %
5,574,545 1.930 % 1 379 M €
Geode Capital Management LLC
1.897 %
5,480,211 1.897 % 1 356 M €
BlackRock Life Ltd.
1.762 %
5,090,294 1.762 % 1 260 M €

Company contact information

Becton, Dickinson & Co.

1 Becton Drive

07417-1880, Franklin Lakes

+201 847 6800

http://www.bd.com
address Becton, Dickinson and Company(BDX)

Group companies

NameCategory and Sector
Becton Dickinson India Pvt Ltd.
Becton Dickinson Luxembourg Finance SARL
Becton, Dickinson & Co. Master Retirement Trust
Investment Managers
Finance/Rental/Leasing
Medical Specialties
  1. Stock Market
  2. Equities
  3. BDX Stock
  4. BDX Stock
  5. Company Becton, Dickinson and Company